Open Access

Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres

  • Authors:
    • Venerando Rapisarda
    • Caterina Ledda
    • Vincenzo Ricceri
    • Francesco Arena
    • Andrea Musumeci
    • Andrea Marconi
    • Lucrezia Fago
    • Massimo Bracci
    • Lory Santarelli
    • Margherita Ferrante
  • View Affiliations

  • Published online on: February 19, 2015     https://doi.org/10.3892/ol.2015.2978
  • Pages: 2046-2052
  • Copyright: © Rapisarda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fluoro‑edenite is a natural mineral species initially isolated in Biancavilla, Sicily. The fibres are similar in size and morphology to certain amphibolic asbestos fibres, the inhalation of which may cause chronic inflammation and cancer. Occupational asbestos exposure is known to be associated with pleural and lung diseases, including pleural plaques. The aim of this study was to report the pleural and lung parenchymal lesions detected by high‑resolution computed tomography (HRCT) in a group of construction workers exposed to fluoro‑edenite. Information regarding life habits and occupational history was collected from 43 workers enrolled into the study. The participants underwent physical examination, blood analysis, search for uncoated fibres and ferruginous bodies in the sputum, pulmonary function tests, including diffusion capacity for carbon monoxide (TLCO), and HRCT chest imaging. A general descriptive outcome analysis was also conducted; a prevalence ratio (PR) with 95% confidence interval and a two‑tailed test P‑value were calculated for pleural plaques using log‑binomial regression, measuring plaque size and thickness, and cumulative exposure index (CEI). The mean values of the functional respiratory tests were within the normal range for all participants. A restrictive ventilatory defect was identified in two (5%) subjects and an obstructive ventilatory defect in three (7%) subjects. TLCO was reduced in two additional participants. Fibres were detected in 19 (44%) of subjects. Pleural involvement was documented in 39 (91%) workers, of whom 31 (72%) had bilateral plaques. Calcifications were detected in 25 (58%) of these participants. PR indicated a progressive increase in the risk of developing pleural lesions with rising CEI, i.e. length of exposure. The present findings demonstrate for the first time the presence of pleural plaques in the lungs of subjects exposed to fluoro‑edenite fibres, and not to asbestos, through residing in Biancavilla and through their occupation.

Introduction

In the late 1990s, a greatly increased standardised rate of mortality from pleural mesothelioma was highlighted by epidemiological surveys in the area of Biancavilla, a Sicilian town on the south west slope of Mount Etna volcano (1,2). Subsequent studies identified an asbestiform mineral fibre in the benmoreitic lava from a local stone quarry. The quarry had been mined from 1950–1998 to extract sand and gravel, which was routinely used by builders to produce pavements and house plaster (2,3). The fibre was identified as fluoro-edenite (4).

Fluoro-edenite (NaCa2Mg5Si7AlO22F2) is a new mineral species recognised by the Commission on New Minerals and Mineral Names (CNMMN; IMA: code 2000–049) in 2001 (5). The fibres are similar in size and morphology to certain amphibolic asbestos fibres (including tremolite, actinolite and antophyllite) (4), the inhalation of which may cause chronic inflammation and pleural mesothelioma (1,2).

Based on previous animal studies, long, thin asbestos fibers (≥8 µm in length and ≤0.25 µm in width) have been postulated to be strongly carcinogenic; inducing pleural malignant mesothelioma, while shorter, thicker fibers are thought to pose a smaller risk (6). The relationship between asbestos exposure and respiratory disease has been studied extensively (7). Occupational exposure to asbestos is known to be associated with pleural and lung diseases, including pleural plaques, pleurisy, fibrosis of the visceral pleura, rounded atelectasis, asbestosis, lung cancer and malignant mesothelioma (8). These diseases, termed asbestos-related diseases, are well documented and approximately 107,000 mortalities are attributable to asbestos exposure worldwide, annually (9,10). Little has been established with regard to the effects of human exposure to fluoro-edenite fibres (1113), however, epidemiological studies have indicated that these fibres may have a causative role in chronic obstructive lung disease (1,14) and malignant pleural mesothelioma (2,14).

The aim of the current study was to evaluate the findings following the assessment of the pleura and lung parenchyma of a group of construction workers residing and working in the area of Biancavilla.

Materials and methods

Subjects

Between 2009 and 2013, 52 male construction workers living and working in the area of Biancavilla were visited within the framework of periodic occupational surveillance and invited to participate in this study. A free medical examination, including a high-resolution computer tomography (HRCT) chest scan, was offered to participants.

Exclusion criteria were broncho-pulmonary diseases (e.g. asthma, bronchopneumonia, and tuberculosis), previous asbestos exposure, and involvement in construction work in the Biancavilla area for <1 year.

A questionnaire was used to collect information about the participants with regard to family, medical history, medication, drinking habits, hobbies, etc. Questions on tobacco consumption enabled participants to be classified as current smokers, ex-smokers (those who had not smoked for >1 year) and non-smokers (those who had never smoked).

The research protocol was approved by the Ethics Committee of Catania University Hospital (Catania, Italy) and the written informed consent of all subjects was acquired prior to their inclusion in the study.

Fluoro-edenite exposure

The questionnaire was used to determine fluoro-edenite exposure based on each participant's occupational history. Duration (years) and dates of exposure were recorded. The intensity of exposure was weighted according to occupation, as follows: Low (electricians) (passive), 0.01; low intermediate (tilers, crane operators), 0.1; high intermediate (painter, shovel operator), 1; high (carpenter, plasterer, plumber), 10. A cumulative exposure index (CEI) to fluoro-edenite was calculated for each subject as the sum of all periods of employment in jobs involving exposure (duration × weighting factor). Due to a lack of data regarding air-borne fibres, and of detailed information on exposure frequency (percentage working time), the CEI was expressed as exposure unit x year rather than as fibres/ml x year. Latency was defined as the interval from the beginning of the first job considered to entail fluoro-edenite exposure, to the date of the HRCT scan performed in the present study.

Clinical parameters

On acquiring a detailed case history, workers were subjected to: i) Physical examination; ii) blood analysis; iii) search for uncoated fibres and ferruginous bodies in sputum; iv) pulmonary function tests and diffusion capacity for carbon monoxide (TLCO); and v) HRCT chest scanning. Respiratory symptoms were graded using the American Thoracic Society (ATS) questionnaire (15).

Venous blood (10 ml) was collected in the morning, following overnight fasting, to determine red blood cell count, haematocrit, haemoglobin levels, white blood cell count, erythrocyte sedimentation rate, C-reactive protein levels and liver enzyme (aspartate aminotransferase and alanine aminotransferase) levels.

Sampling and fibre search were conducted according to the protocol by Putzu et al (16). Sputum was classified as negative or positive for uncoated fibres and ferruginous bodies (detection limit, 120 ppm).

Respiratory function tests were conducted using a bell spirometer (Biomedin, Padova, Italy) (17). Equipment, calibration and manoeuvres met ATS guidelines (15). Forced vital capacity, forced expiratory volume in 1 s, peak expiratory flow, maximal expiratory flow rate at 25–75% of the vital capacity, total lung capacity, and TLCO were measured and expressed as a proportion of European Coal and Steel Community reference values adjusted for individual characteristics (age, weight and height) recorded at the time of testing (18).

Subjects underwent HRCT scanning with the use of an Optima CT 580W (GE Healthcare, Fairfield, CT, USA), without contrast enhancement, according to a specifically devised protocol: The entire chest was screened using spiral acquisition sequences with the subject in supine position. Interstitial or pleural abnormalities were recorded in standardised form using the Fleischner Society glossary of terms (16). Pleural plaques were defined as circumscribed quadrangular elevations with sharp borders and density comparable to tissue, with/without signs of calcification. Thickness was classified, based on the thickest plaque, into four categories (<2 mm, 2-<5 mm, 5-<10 mm and ≥10 mm). Cut-off criteria were selected and adapted from the International Labour Office classification of radiographs of pneumoconiosis (16).

Parenchymal abnormalities (subpleural dependent opacity, subpleural curvilinear opacities, subpleaural perpendicular lines, parenchymal nodules, honeycombing and ground glass opacities) were recorded and classified by three chest radiologists using a semiquantitative 10-class scale including six subclasses; 0 (no finding), 1 (normal), 2 (subnormal; one or two abnormalities located sporadically in the lung periphery, no honeycombing), 3 (mild fibrosis; at least two abnormalities located on both sides and in several slices from the lung periphery, no honeycombing), 4 (moderate fibrosis; several criteria, which extend deeper into the lung, honeycombing as a general rule), 5 (severe fibrosis; several abnormalities or associated findings extending deep into the lung, honeycombing, lung architectural change) and 6 (extreme fibrosis; extremely severe and various fribrotic changes, little normally aerated lung remaining) as previously described by Gangemi et al (17).

Statistical analysis

Data analysis was performed using SPSS software version 20 (IBM, Milan, Italy). The main population characteristics, respiratory test results and characteristics of the pleural plaques were expressed as the mean ± standard deviation (SD) or as the total number of participants with that characteristic and the percentage represented by that number. The variables used to determine fluoro-edenite exposure were exposure duration, CEI, and the interval between earliest exposure and the HRCT scan conducted during the present study.

A prevalence ratio (PR) with 95% confidence interval (CI) and two-tailed test P-value were calculated for pleural plaques using log-binomial regression, measuring plaque size and thickness, and CEI. Potential confounders were identified from the literature and included in the analysis; the confounding factors used in the models were age and smoking status. Age was modeled as a continuous variable while smoking status was dichotomised as smoker and ex-smoker versus non-smoker.

Results

Application of the exclusion criteria led to the exclusion of nine subjects, due to previous exposure to asbestos (n=5), bronchopneumonia (n=2), tuberculosis (n=1) or allergic bronchial asthma (n=1), leaving 43 participants, whose characteristics are reported in Table I. All 43 workers included in the study had been residing in Biancavilla for >40 years, and 65% (n=28) were born there. Additionally, all had been working almost exclusively in and around Biancavilla. The occupational history recorded from the participants revealed that 38 (88%) had personally handled and mixed gravel from the Mount Calvario quarry until 1998. Furthermore, all had been involved in restoring houses that had been built in the 1950s, when lava from the quarry had been extensively used as a building material. Smokers, ex-smokers and non-smokers did not differ significantly with regard to any study parameter.

Table I.

Characteristics of the study population of exposed workers (n=43).

Table I.

Characteristics of the study population of exposed workers (n=43).

Patient characteristicsParticipants
Age, mean ± SD, years49.3±6.7
Occupation, n (%)
  Unskilled construction worker16 (37)
  Specialised construction worker14 (33)
  Carpenters13 (30)
Duration of residence in Biancavilla, mean ± SD, years44.7±10.3
Smoking habits, n (%)
  Current smokersa13 (30)
  Ex-smokersa16 (37)
  Non-smokersa14 (33)
CEI to fluoro-edenite (exposure unit × years), n (%)
  1–93 (5)
  10–1911 (25)
  20–2919 (44)
  30–397 (19)
  ≥403 (7)

a Lack of significant differences between smokers, ex-smokers and non-smokers. CEI, cumulative exposure index; SD, standard deviation.

A CEI ranging from 10–29 was determined in the majority of participants (n=30; 70%). Respiratory symptoms were identified in six (14%) workers: Four (10%) had a cough and two (5%) had mild (grade I) dyspnoea. Other identified conditions not involving the respiratory apparatus were: Arterial hypertension (n=5; 12%), type II diabetes mellitus (n=2; 5%), dyslipidaemia (n=4; 10%), dysthyroidism (n=3; 7%) and prostatic hypertrophy (n=1; 2%). All conditions were being treated. Blood examination to determine red blood cell count, haematocrit, haemoglobin levels, white blood cell count, erythrocyte sedimentation rate, C-reactive protein levels and liver enzyme (aspartate aminotransferase and alanine aminotransferase) levels revealed that two participants (the two diabetic subjects) had hyperglycaemia (blood glucose level, >125 mg/dl); the parameters of the other workers were within the normal range.

The results from the respiratory tests and the search for uncoated fibres and ferruginous bodies in sputum are reported in Table II. The mean values (% predicted) of the functional respiratory tests were within the normal range for all participants. A restrictive ventilatory defect was discovered in two (5%) subjects and an obstructive ventilatory defect observed in three (7%). TLCO was reduced in two additional participants. Overall, a slight non-significant reduction in predictive values (%) was noted with rising CEI (range, 30-≥40). Fluoro-edenite fibres, but not fibre bundles, were recovered from the sputum of 19 (44%) workers. The length of the fibres ranged from 10–35 µm, with a diameter of <0.5 µm. Ferruginous bodies were not identified in any of the samples.

Table II.

Results of respiratory tests (expressed as % predicted mean ± SD) and sputum examination (expressed as n and %) of participants, subdivided by occupational CEI values.

Table II.

Results of respiratory tests (expressed as % predicted mean ± SD) and sputum examination (expressed as n and %) of participants, subdivided by occupational CEI values.

CEI1–910–1920–2930–39≥40
Subjects, n (%a)2 (5)9 (21)23 (53)7 (16)2 (5)
Smokers, n (%b)3 (23)4 (31)3 (23)2 (15)1 (8)
FVC, %98.2±5.797.7±1.196.9±1.692.9±6.790.8±8.6
FEV1, %98.8±7.895.5±1.393.6±1.487.6±6.583.3±9.1
PEF, %97.6±7.995.2±6.492.3±5.790.7±6.986.9±9.6
MEF25–75, %94.5±8.694.3±9.189.5±6.385.2±6.182.5±8.7
TLC, %96.6±5.695.5±3.390.3±7.288.9±5.187.7±5.4
TLCO, %96.9±6.495.4±6.690.2±4.181.5±5.779.3±6.4
Fibres present in sputum, n (%c)0 (0)4 (21)12 (63)2 (11)1 (5)

a Percentage of total number of subjects (n=43)

b percentage of total number of smokers

c percentage of total number of patients with fibres present in sputum (n=19). CEI, cumulative exposure index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; PEF, peak expiratory flow; MEF25–75, maximal expiratory flow rate at 25–75% of the vital capacity; TLC, total lung capacity; TLCO, diffusion capacity for carbon monoxide.

The HRCT findings in lung parenchyma are reported in Table III. HRCT scans revealed low-grade fibrosis in seven workers (two unilateral and five bilateral) and unilateral rounded atelectasis in two workers. Pleural involvement was documented in 39 (91%) subjects, of whom 31 (72%) had bilateral plaques. Calcifications were detected in 25 (58%) participants (Table IV). Examples of HRCT scans acquired from these participants are shown in Figs. 1 and 2. Calculation of plaque PR with 95% CI, and the P-value from the two-tailed test by log-binomial regression, demonstrated a progressive increase in the risk of developing pleural lesions with rising CEI, i.e. length of exposure (Table V).

Table III.

High-resolution computed tomography findings in the lung parenchyma of 43 workers.

Table III.

High-resolution computed tomography findings in the lung parenchyma of 43 workers.

Subjects with unilateral abnormalities, n (%; mean score ± SD)Subjects with bilateral abnormalities, n (%; mean score ± SD)
Rounded atelectasis2 (5%; 1.12±0.23)0
Emphysema00
Thickness00
Bronchiectasis00
Fibrosis2 (5%; 1.43±0.32)5 (12%; 2.07±0.65)

Table IV.

Characteristics of the pleural plaques detected by high-resolution computed tomography in 39 participants.

Table IV.

Characteristics of the pleural plaques detected by high-resolution computed tomography in 39 participants.

Plaque featuresUnilateral plaques, n (%a)Bilateral plaques, n (%b)Total, n (%c)
Thickness, mm
  <20 (0%)5 (16%)5 (13%)
  2–4.95 (62%)10 (32%)15 (38%)
  5–9.93 (38%)9 (29%)12 (31%)
  ≥100 (0%)7 (23%)7 (18%)
Size
  <1 cm0 (0%)4 (15%)4 (10%)
  1 cm-24% of lateral chest wall4 (50%)15 (48%)22 (49%)
  24–49% of lateral chest wall4 (50%)9 (29%)14 (33%)
  ≥0% of lateral chest wall0 (0%)3 (10%)3 (8%)  
Calcification4 (50%)21 (54%)25 (58%)

a Percentage of patients with unilateral plaques (n=8)

b percentage of patients with bilateral plaques (n=31)

c percentage of patients with unilateral or bilateral plaques (n=39).

Table V.

PR with 95% CI and two-tailed test P-value were calculated for the pleural plaques in the 39 (91%) participants using log-binomial regression taking into consideration plaque size and thickness and CEI.

Table V.

PR with 95% CI and two-tailed test P-value were calculated for the pleural plaques in the 39 (91%) participants using log-binomial regression taking into consideration plaque size and thickness and CEI.

Risk indicators

CEI to fluoro-edeniteaPRCIP-value
1–91.00
10–191.451.12–1.78>0.05
20–291.981.84–2.12>0.001
30–392.362.01–2.58>0.001
≥403.323.24–3.48>0.001

a Exposure unit x years. PR, prevalence ratio; CI, confidence interval; CEI, cumulative exposure index.

Discussion

Exposure to asbestiform fibres similar to that described in Biancavilla has been reported for erionite in the central Anatolian villages of Karain and Tuzkoy (2123). Erionite is a fibrous zeolite found in the natural rock material used locally for building (24,25). As in Biancavilla, a high mortality rate from pleural carcinoma (sentinel event) allowed for the recognition of population exposure and, consequently, occupational exposure, particularly for construction workers.

For decades, fluoro-edenite has been considered predominantly as a synthetic fibre (2628). The natural environments from which it had previously been discovered include the Pargas region in Finland (29), the Utah Rocky Mountains (30) and the Orange area in New Jersey (31). However, Biancavilla is the first and sole instance involving human exposure (2,3). Additionally, the fibres recovered from the lava of the Kimpo volcano in Kumamoto Prefecture (Japan) are structurally similar to Biancavilla's fluoro-edenite (32), however, they have never been submitted to the CNMMN, nor has human exposure been described.

The type of environmental contamination discovered in Biancavilla (22,33,34) suggests that the entire population is exposed to fluoro-edenite (1). Construction workers are at increased risk due to additional exposure to fibres present in the cement and plaster made with contaminated material from the Mount Calvario quarry (2,3).

The respiratory function tests and HRCT imaging conducted in the present study enabled the evaluation of the effects of fluoro-edenite fibres on subjects who are both residents and occupationally exposed subjects. The results document a broad involvement of the respiratory apparatus, and a greater involvement of the pleura (39/43) compared with the lung. However, these lesions have a limited effect on respiratory function, as has been demonstrated from the results of the spirometry. The respiratory function data collected in the present study are consistent with those of other studies conducted on construction workers with pleural plaques related to occupational asbestos exposure (3538).

Pleural plaques are circumscribed, thickened areas, consisting of avascular connective tissue, localised to the parietal and/or diaphragmatic pleura of asbestos-exposed subjects (38). They may reflect a local (pleural) response to asbestos fibre accumulation, and are typically detected in exposed construction workers (39). Plaques indicate consistent exposure to low fibre concentrations (0.19 fibre-years/ml) (40). Other potential pleural responses include lymph node calcification and carcinogenesis (41,42). The results of the current study are consistent with those of other studies, which reported that, in cases of chest wall pleural plaques detected in asbestos-exposed construction workers, ~70% exhibit lesions on both sides of the chest (20,39,43), and ~30% also exhibit calcifications (25% in the current sample) (20,39).

Subjects with pleural plaques are at greater risk of lung cancer and malignant pleural mesothelioma, compared with the general population (38,41,42,44). Inhalation of asbestos fibres may induce two types of interconnected pathogenic processes involving the respiratory apparatus: Chronic inflammation or carcinogenesis. These effects are related to the ability of fibres to disrupt mitotic mechanisms, stimulate host cell proliferation, induce release of free radicals (resulting in DNA damage), and prolong the release of cytokines and growth factors (45,46). In vivo and in vitro analysis of the biological reactivity of fluoro-edenite fibres has also demonstrated that they are able to cause the production of reactive oxygen species, stimulation of the intrinsic and extrinsic apoptosis pathways, and induction of inflammatory processes through the activation of specific cytokines (4751).

With regard to the recovery of fibres from sputum, the current data are consistent with those of Putzu et al (16), who described fibres similar to those found in the present study in 50% (6/12) of their sample of Biancavilla residents (vs. 44%, or 19/43, in the current study). That these subjects were four housewives, a farmer and a mason, with no history of exposure to fluoro-edenite fibres, indicates a predominantly environmental exposure.

Environmental contamination had previously been demonstrated by examination of the lungs and lymph nodes of sheep whose pastures lay a few kilometres from Biancavilla (33,34). Therefore the risk of inhalation of dust particles, particularly fluoro-edenite fibres, from Mount Calvario quarry is high even in open, non-urban areas located a short distance away from this region (33,34). Such contamination is likely to be the cause of the pleural plaques detected in the lungs of the construction workers in the current study with a relatively short occupational exposure (low CEI). The significantly greater plaque size and thickness observed in workers with a higher CEI may indicate a combination of environmental and occupational exposure, thus increasing the risk of development of respiratory conditions in these individuals (52).

A form of biphasic pollution may be hypothesised for fluoro-edenite, as proposed for asbestos fibres (53). As sand from the Mount Calvario quarry is commonly used locally in the production of building materials, the maintenance, repair and restructuring work conducted over the years may have induced the fragmentation of larger particles and fibres into smaller particles and fibres, capable of remaining airborne for a long period, and of disseminating over considerable distances.

The present findings demonstrate for the first time pleural plaques in the lungs of subjects not exposed to asbestos, but to fluoro-edenite fibres, through living and working in Biancavilla. The data indicate the requirement to establish a population screening programme for conditions associated with fibre exposure. All sources of occupational exposure to fluoro-edenite fibres must be identified and measures should be taken to minimise this exposure, including periodic environmental fibre monitoring and adaptation of a surveillance protocol to consider the health effects of fibres, assess risks and calculate the cost-benefit ratio of the monitoring programme.

The present, preliminary study is of value as it describes pleural plaques that may be ascribed to exposure to fluoro-edenite fibres. Investigation of the resident population and of larger cohorts of exposed workers is required to gain further insights.

Acknowledgements

The authors would like to thank Dr Marine Castaing (Cancer Registry of Catania-Messina-Siracusa-Enna; University of Catania, Catania, Italy) for her assistance and support.

References

1 

Di Paola M, Mastrantonio M and Carboni M: Mortality from malignant pleural neoplasms in Italy in the years 1988–1992Rapporti ISTISAN 96/40. Rome, Italy: pp. 1–30. 1996

2 

Paoletti L, Batisti D, Bruno C, et al: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI

3 

Rapisarda V, Amati M, Coloccini S, et al: The in vitro release of hydroxyl radicals from dust containing fluoro-edenite fibers identified in the volcanic rocks of Biancavilla (eastern Sicily). Med Lav. 94:200–206. 2003.[(In Italian)]. PubMed/NCBI

4 

Comba P, Gianfagna A and Paoletti L: Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 58:229–232. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Gianfagna A and Oberti R: Fluoro-edenite from Biancavilla (Catania, Sicily, Italy): Crystal chemistry of a new amphibole end-member. Am Mineral. 86:1489–1493. 2001.

6 

Stanton MF, Layard M, Tegeris A, et al: Relation of particles dimension to carcinogenicity in amphibole asbestoses and fibrous minerals. J Natl Cancer Inst. 67:965–975. 1981.PubMed/NCBI

7 

Bernstein D, Dunnigan J, Hesterberg T, et al: Health risk of chrysotile revisited. Crit Rev Toxicol. 43:154–183. 2003. View Article : Google Scholar

8 

Becklake MR, Bagatin E and Neder JA: Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis. 11:356–69. 2007.PubMed/NCBI

9 

Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005. View Article : Google Scholar : PubMed/NCBI

10 

World Health Organization: Asbestos: elimination of asbestos-related diseases. http://www.who.int/mediacentre/factsheets/fs343/en/Accessed. January 20–2015

11 

Fazzo L, Minelli G, De Santis M, et al: Mesothelioma mortality surveillance and asbestos exposure tracking in Italy. Ann Ist Super Sanita. 48:300–310. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Loreto C, Carnazza ML, Cardile V, et al: Mineral fiber-mediated activation of phosphoinositide-specific phospholipase c in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells. Int J Oncol. 34:371–376. 2009.PubMed/NCBI

13 

Musumeci G, Loreto C, Cardile V, et al: Immunohistochemical expression of retinoblastoma and phospho-retinoblastoma protein in sheep lung exposed to fluoro-edenite fibers. Anat Sci Int. 85:74–78. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Biggeri A, Pasetto R, Belli S, et al: Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Scand J Work Environ Health. 30:249–252. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 152:S77–S121. 1995.PubMed/NCBI

16 

Putzu MG, Bruno C, Zona A, et al: Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study. Environ Health. 5:202006. View Article : Google Scholar : PubMed/NCBI

17 

Gangemi S, Rapisarda V, Minciullo PL, et al: Circulating levels of interleukin-18 in asbestos-exposed workers. Toxicol Ind Health. 21:125–129. 2005. View Article : Google Scholar

18 

Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J. 26:319–338. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Hansell DM, Bankier AA, MacMahon H, et al: Fleischner Society: glossary of terms for thoracic imaging. Radiology. 246:697–722. 2008. View Article : Google Scholar : PubMed/NCBI

20 

International Labour Organization, . ILO standards-related activities in the area of occupational safety and health: An in-depth study for discussion with a view to the elaboration of a plan of action for such activities. Report VI. Geneva, International Labour Office. 2003.

21 

Bariş B, Demir AU, Shehu V, et al: Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. J Environ Pathol Toxicol Oncol. 15:183–189. 1996.PubMed/NCBI

22 

Temel A and Gündoǧdu MN: Zeolite occurrences and the erionite-mesothelioma relationship in Cappadocia, central Anatolia, Turkey. Miner Deposita. 31:539–547. 1996. View Article : Google Scholar

23 

Dogan AU: Mesothelioma in Cappadocian villages. Indoor Built Env. 12:367–375. 2003. View Article : Google Scholar

24 

Metintas M, Hillerdal G and Metintas S: Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Eur Respir J. 13:523–526. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Roushdy-Hammady I, Siegel J, Emri S, et al: Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 357:444–445. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Boschmann KF, Burns PC, Hawthorne FC, et al: A-site disorder in synthetic fluor-edenite, a crystal-structure study. Can Mineral. 32:21–30. 1994.

27 

Eugene CJ and Arnold KJ: Study on synthetic fluor-tremolite, part 1 of synthetic asbestos investigations. Am Mineral. 39:537–548. 1954.

28 

Robert JL, Della Ventura G and Thauvin JL: The infrared OH-stretching region of synthetic richterites in the system Na2O-K2O-CaO-MgO-SiO2-H2O-HF. Eur J Mineral. 1:203–212. 1989. View Article : Google Scholar

29 

Laitakari A: Uber die Petrographie der kalksteingerstatten von Parainen (Pargas). Bulletin de la Commission Geologique de Finlande. 54:101921.

30 

Moore JN and Kerrick DM: Equilibria in siliceous dolomites of the Alta aureole. Utah. Am J Sci. 276:502–524. 1976. View Article : Google Scholar

31 

Kearns LE, Kite LE, Leavens PB and Nelen JA: Fluorine distribution in the hydrous silicate minerals of the Franklin Marble, Orange County, New York. Am Mineral. 65:557–562. 1980.

32 

Makino K, Yamaguchi Y and Tomita K: Fluor edenite from the Ishigamiyama lava dome of the Kimpo volcano, Kumamoto, southwest Japan. GANKO. 91:419–423. 1996.[(In Japanese)].

33 

DeNardo P, Bruni B, Paoletti L, et al: Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): preliminary results. Sci Total Environ. 325:51–58. 2004. View Article : Google Scholar : PubMed/NCBI

34 

Rapisarda V, Rapisarda G, Vico GD, et al: Monitoring of fluoro-edenite fibre pollution through the study of sheep lymph nodes as a model of a biological indicator. Occup Environ Med. 62:6562005. View Article : Google Scholar : PubMed/NCBI

35 

Kilburn KH, Powers D and Warshaw RH: Pulmonary effects of exposure to fine fibreglass: irregular opacities and small airways obstruction. Br J Ind Med. 49:714–720. 1992.PubMed/NCBI

36 

Albin M, Engholm G, Hallin N and Hagmar L: Impact of exposure to insulation wool on lung function and cough in Swedish construction workers. Occup Environ Med. 55:661–667. 1998. View Article : Google Scholar : PubMed/NCBI

37 

Sripaiboonkij P, Sripaiboonkij N, Phanprasit W and Jaakkola MS: Respiratory and skin health among glass microfiber production workers: a cross-sectional study. Environ Health. 8:362009. View Article : Google Scholar : PubMed/NCBI

38 

Pairon J, Laurent F, Rinaldo M, et al: Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst. 105:293–301. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Elshazley M, Shibata E, Hisanaga N, et al: Pleural plaque profiles on the chest radiographs and CT scans of asbestos-exposed Japanese construction workers. Ind Health. 49:626–633. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Metintas M, Metintas S, Hillerdal G, et al: Nonmalignant pleural lesions due to environmental exposure to asbestos: A field-based, cross-sectional study. Eur Respir J. 26:875–880. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Hillerdal G and Henderson DW: Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 23:93–103. 1997. View Article : Google Scholar : PubMed/NCBI

42 

Hillerdal G: Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest. 105:144–150. 1994.

43 

Perticaroli P, Mengucci R, Carletti M, et al: Asbestos-related diseases in former asbestos-cement workers in Senigallia. Med Lav. 104:277–288. 2013.[(In Italian)]. PubMed/NCBI

44 

American Thoracic Society, . Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 170:691–715. 2004. View Article : Google Scholar : PubMed/NCBI

45 

Kamp DW and Weitzman SA: The molecular basis of asbestos induced lung injury. Thorax. 54:638–652. 1999. View Article : Google Scholar : PubMed/NCBI

46 

Kamp DW: Asbestos-induced lung diseases: an update. Transl Res. 153:143–152. 2009. View Article : Google Scholar : PubMed/NCBI

47 

Soffritti M, Minardi F, Bua L, et al: First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibres present in Etnean volcanic material from Biancavilla (Sicily, Italy). Eur J Oncol. 9:169–175. 2004.

48 

Loreto C, Rapisarda V, Carnazza ML, et al: Fluoro-edenite fibres induce lung cell apoptosis: an in vivo study. Histol Histopathol. 23:319–326. 2008.PubMed/NCBI

49 

Martinez G, Musumeci G, Loreto C and Carnazza ML: Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia. J Mol Histol. 38:295–302. 2007. View Article : Google Scholar : PubMed/NCBI

50 

Travaglione S, Bruni B, Falzano L, et al: Effects of the new-identified amphibole fluoro-edenite in lung epithelial cells. Toxicol In Vitro. 17:547–552. 2003. View Article : Google Scholar : PubMed/NCBI

51 

Cardile V, Renis M, Scifo C, et al: Behaviour of the new asbestos amphibole fluor-edenite in different lung cell systems. Int J Biochem Cell Biol. 36:849–860. 2004. View Article : Google Scholar : PubMed/NCBI

52 

Ledda C, Rapisarda V, Bracci M, et al: Professional exposure to basaltic rock dust: assessment by the Vibrio fischeri ecotoxicological test. J Occup Med Toxicol. 8:232013. View Article : Google Scholar : PubMed/NCBI

53 

Chiappino G, Sebastien P and Todaro A: Atmospheric asbestos pollution in the urban environment: Milan, Casale Monferrato, Brescia, Ancona, Bologna and Florence. Med Lav. 82:424–438. 1991.[(In Italian)]. PubMed/NCBI

Related Articles

Journal Cover

May-2015
Volume 9 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Rapisarda V, Ledda C, Ricceri V, Arena F, Musumeci A, Marconi A, Fago L, Bracci M, Santarelli L, Ferrante M, Ferrante M, et al: Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres. Oncol Lett 9: 2046-2052, 2015.
APA
Rapisarda, V., Ledda, C., Ricceri, V., Arena, F., Musumeci, A., Marconi, A. ... Ferrante, M. (2015). Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres. Oncology Letters, 9, 2046-2052. https://doi.org/10.3892/ol.2015.2978
MLA
Rapisarda, V., Ledda, C., Ricceri, V., Arena, F., Musumeci, A., Marconi, A., Fago, L., Bracci, M., Santarelli, L., Ferrante, M."Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres". Oncology Letters 9.5 (2015): 2046-2052.
Chicago
Rapisarda, V., Ledda, C., Ricceri, V., Arena, F., Musumeci, A., Marconi, A., Fago, L., Bracci, M., Santarelli, L., Ferrante, M."Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres". Oncology Letters 9, no. 5 (2015): 2046-2052. https://doi.org/10.3892/ol.2015.2978